London Health Sciences Centre
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1875-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.lhsc.on.ca
Clinical Trials
39
Active:1
Completed:16
Trial Phases
6 Phases
Early Phase 1:2
Phase 1:3
Phase 2:6
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (32 trials with phase data)• Click on a phase to view related trials
Not Applicable
15 (46.9%)Phase 2
6 (18.8%)Phase 4
4 (12.5%)Phase 1
3 (9.4%)Early Phase 1
2 (6.3%)Phase 3
2 (6.3%)Therapeutic Normothermia in TBI
Not Applicable
Not yet recruiting
- Conditions
- Traumatic Brain Injury
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 50
- Registration Number
- NCT06540768
Use of 81 vs 325mg of ASA in Treatment of BCVI
Early Phase 1
Not yet recruiting
- Conditions
- Carotid Artery InjuriesTraumatic InjuryVertebral Artery Injury
- Interventions
- First Posted Date
- 2024-04-25
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 40
- Registration Number
- NCT06383650
Propranolol for the Treatment of Traumatic Brain Injury
Early Phase 1
Not yet recruiting
- Conditions
- TBI (Traumatic Brain Injury)
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-02-15
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 50
- Registration Number
- NCT06262061
Shared Decision Making in Paediatric Inflammatory Bowel Disease
Not Applicable
Not yet recruiting
- Conditions
- Ulcerative ColitisInflammatory Bowel DiseasesIBDCrohn Disease
- First Posted Date
- 2023-01-19
- Last Posted Date
- 2023-12-11
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 150
- Registration Number
- NCT05689892
Intravascular Ultrasound for the Evaluation of Malperfusion Syndrome in the Setting of Acute Aortic Dissection
Not Applicable
- Conditions
- Perfusion; ComplicationsAortic Dissection
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- London Health Sciences Centre
- Target Recruit Count
- 50
- Registration Number
- NCT04907071
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
Novel Fecal Microbiota Pill Enters Clinical Trial for Advanced Pancreatic Cancer Treatment
Canadian researchers launch Phase 1 trial of LND101, an oral fecal transplant therapy, targeting pancreatic cancer's dismal 10% five-year survival rate.